Disc Medicine, Inc.

XNASHealth care

Last traded price · USD

$87.50

+7.81%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:25 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $81.16
Volume: 1.4M
Day's high: —
Day's low: —

In brief

Disc Medicine, Inc. is a health care company listed on Nasdaq, valued at about $3.88B.
Its shares closed at $83.28 on 4 Nov 2026, down 3.2% over the past year.
From India you can buy IRON in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Disc Medicine, Inc. (IRON) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole IRON share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade IRON options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +35.1% (SPY −1.6%, XLV +13.5%). 3 months: +5.5% (SPY −0.4%, XLV +15.5%). 1 year: −3.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: IRON, SPY and XLV · as of 4 Nov 2026
10.6 days to cover short interest
7.5M shares were sold short at the 15 Oct 2026 settlement, 19.4% of the 38.4M shares outstanding; covering them would take 10.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $83.28 was 16.7% above its 50-day average ($71.36) and 17.6% above its 200-day average ($70.82). It has closed above the 200-day for 13 sessions, since 19 Oct 2026. The 50-day average crossed above the 200-day on 17 Aug 2026, 56 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
73% of the way up its 52-week range
Closed at $83.28 on 4 Nov 2026: 16.3% below the 52-week high of $99.50 (8 Dec 2025) and 108.2% above the low of $40.00 (13 Feb 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+35.1%

6 months+21.3%

1 year−3.2%

5 years—

Newswire

About

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Website

Notable moves

October 19, 2026
+38.86%
November 4, 2024
+23.59%
April 1, 2024
−45.05%

Newswire

About

Website

Notable moves

October 19, 2026
+38.86%
November 4, 2024
+23.59%
April 1, 2024
−45.05%

Disc Medicine, Inc.

XNASHealth care

Last traded price · USD

$87.50

+7.81%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:25 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $81.16
Volume: 1.4M
Day's high: —
Day's low: —

In brief

Disc Medicine, Inc. is a health care company listed on Nasdaq, valued at about $3.88B.
Its shares closed at $83.28 on 4 Nov 2026, down 3.2% over the past year.
From India you can buy IRON in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Disc Medicine, Inc. (IRON) shares from India?

Do I need the price of a whole IRON share to invest?

How much can I invest in US stocks in a year?

Can I trade IRON options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +35.1% (SPY −1.6%, XLV +13.5%). 3 months: +5.5% (SPY −0.4%, XLV +15.5%). 1 year: −3.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: IRON, SPY and XLV · as of 4 Nov 2026
10.6 days to cover short interest
7.5M shares were sold short at the 15 Oct 2026 settlement, 19.4% of the 38.4M shares outstanding; covering them would take 10.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $83.28 was 16.7% above its 50-day average ($71.36) and 17.6% above its 200-day average ($70.82). It has closed above the 200-day for 13 sessions, since 19 Oct 2026. The 50-day average crossed above the 200-day on 17 Aug 2026, 56 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
73% of the way up its 52-week range
Closed at $83.28 on 4 Nov 2026: 16.3% below the 52-week high of $99.50 (8 Dec 2025) and 108.2% above the low of $40.00 (13 Feb 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+35.1%

6 months+21.3%

1 year−3.2%

5 years—

Newswire

About

Website

Notable moves

October 19, 2026
+38.86%
November 4, 2024
+23.59%
April 1, 2024
−45.05%

Newswire

About

Website

Notable moves

October 19, 2026
+38.86%
November 4, 2024
+23.59%
April 1, 2024
−45.05%

Disc Medicine, Inc.

Disc Medicine, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

10.6 days to cover short interest

Above its 50- and 200-day averages

73% of the way up its 52-week range

Disc Medicine, Inc.

Disc Medicine, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

10.6 days to cover short interest

Above its 50- and 200-day averages

73% of the way up its 52-week range